IP Library › Granted Patent US 8,058,065
Granted Patent B2
US 8,058,065 · App. 12/457,356 · Granted Nov 15, 2011

Oct3/4, Klf4, c-Myc and Sox2 produce induced pluripotent stem cells

Assignee: Kyoto University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,058,065
App. No.
12/457,356
Granted
Nov 15, 2011
Kind
B2
Abstract

The present invention relates to a nuclear reprogramming factor having an action of reprogramming a differentiated somatic cell to derive an induced pluripotent stem (iPS) cell. The present invention also relates to the aforementioned iPS cells, methods of generating and maintaining iPS cells, and methods of using iPS cells, including screening and testing methods as well as methods of stem cell therapy. The present invention also relates to somatic cells derived by inducing differentiation of the aforementioned iPS cells.

Claims (2)

1. A method for preparing an induced pluripotent stem cell by nuclear reprogramming of a somatic cell from a mammalian species, comprising:

a) introducing into the somatic cell one or more retroviral vectors comprising a gene encoding Oct3/4, a gene encoding Klf4, a gene encoding c-Myc and a gene encoding Sox2 operably linked to a promoter; and b) culturing the transduced somatic cell on a fibroblast feeder layer or extracellular matrix in a cell media that supports growth of ES cells of the mammalian species, wherein one or more pluripotent cells are obtained.

Priority Claims (1)
JP 2005-359537 · Dec 13, 2005 · national
Continuity (5)
Continuation 12213035 · Jun 13, 2008
Continuation In Part PCTJP2006324881 · Dec 6, 2006
Provisional Application 61001108 · Oct 31, 2007
Provisional Application 60996289 · Nov 9, 2007
Related Publication 20100062533A1 · Mar 11, 2010